FDA accepts Aquestive Anaphylm application for review
Aquestive Therapeutics (NASDAQ:AQST) received FDA acceptance for its Anaphylm resubmission with a March 16, 2027 action date.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Aquestive Therapeutics (NASDAQ:AQST) received FDA acceptance for its Anaphylm resubmission with a March 16, 2027 action date.
Redwire Corporation (NYSE:RDW) secured purchase orders valued at $13.8 million to supply Stalker Uncrewed Aircraft Systems to the National Guard Bureau.
Cronos Group (NASDAQ:CRON) completed its acquisition of CanAdelaar for a base purchase price of €57.5 million.
The US producer price index for September advanced 1.3% from a month earlier the most since March 2022 and 6.3% from a year earlier, according to Bureau of Labor Statistics data out Thursday. Energy prices rose 10.8% in September. Bloomberg's Enda Curran reports.
MGP Ingredients (NASDAQ:MGPI) will officially rebrand as Sempreon on November 2, 2026, unifying three operating divisions.
Youlife (NASDAQ:YOUL) reported first-half 2026 revenue of RMB1,961.9 million, driven by its expanded workforce platform.
Eli Lilly (NYSE:LLY) reported that 27.7 percent of ulcerative colitis patients on Omvoh achieved corticosteroid-free disease control at one year.
The Charles Schwab Corporation (NYSE:SCHW) reported third-quarter 2026 adjusted earnings per share of $1.69 to top analyst projections.
SenesTech (NASDAQ:SNES) reported preliminary third-quarter 2026 revenue of approximately $1.1 million.
SEALSQ (NASDAQ:LAES) reported preliminary unaudited revenue of $16.3 million for the nine months ended September 30, 2026, marking a 65% year-over-year increase.
Jeff Currie, CEO at Real Macro, says the US focus on issues with diesel prices is "going to make the gasoline problem likely far worse." He advocates owning the energy equities in what he calls "the revenge of the old economy" in a rotation out of tech.
Kandal M Venture (NASDAQ:FMFC) reported first-half fiscal 2027 gross profit of US$2.150 million, representing a 45.3% year-over-year increase.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade